Longitudinal Study of the Effect of Calcium Pidolate on Bone Mass in Eugonadal Women

Overview

Journal Calcif Tissue Int

Specialty Pathology

Date 1994 Jun 1

PMID 8082050

Citations 2

Authors

H Rico

M Revilla

L F Villa

M Alvarez de Buergo

I Arribas

Affiliations

Soon will be listed here.

Abstract

Seventy-two eugonadal women, mean age 39 +/- 4 years, with a z score for total body bone mineral content (BMC) of less than -1.5 (mean -1.80 +/- 0.12) were selected from a previous screening study of normal values of total body and regional BMC in women using dual-energy X-ray absorptiometry. The women were distributed into two groups: 36 women undergoing treatment with 1 g/day of elemental calcium in the form of calcium pidolate and 36 women not treated. One year later, total body BMC, regional BMC in arms, legs and trunk, 24-hour urinary calcium excretion (Ca 24 hour), fasting urinary calcium/creatinine ratio, and serum tartrate-resistant acid phosphatase concentration were measured in both groups. There was a significant increase in total body and regional BMC (P < 0.001) in the group taking calcium pidolate. The increase was greater in arms and legs (2.5%) than in trunk (1.7%), being 2.6% for total body BMC. The z score increased from -1.81 +/- 0.13 to -1.52 +/- 0.12 (16%, P < 0.001). The corporal index did not change, and total body BMC corrected for fat-free body mass increased by 6.7% (P < 0.001). These changes were accompanied by an increase in 24-hour urinary calcium excretion and a decrease in urinary calcium/creatinine ratio and serum tartrate-resistant acid phosphatase concentration (P < 0.05 for all). There was a correlation between cumulative calcium dose at the end of treatment and gain in total body BMC (r2 = 0.925, P < 0.001). The untreated group showed no changes.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Brown J, Josse R CMAJ. 2002; 167(10 Suppl):S1-34.

PMID: 12427685 PMC: 134653.

Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers.

Deroisy R, Zartarian M, Meurmans L, Nelissenne N, Micheletti M, Albert A Clin Rheumatol. 1997; 16(3):249-53.

PMID: 9184261 DOI: 10.1007/BF02238959.

References

Sentipal J, Wardlaw G, Mahan J, Matkovic V . Influence of calcium intake and growth indexes on vertebral bone mineral density in young females. Am J Clin Nutr. 1991; 54(2):425-8. DOI: 10.1093/ajcn/54.2.425. View

Wolman R, Clark P, McNally E, Harries M, Reeve J . Dietary calcium as a statistical determinant of spinal trabecular bone density in amenorrhoeic and oestrogen-replete athletes. Bone Miner. 1992; 17(3):415-23. DOI: 10.1016/0169-6009(92)90790-k. View

Marchandise X, Pagniez D, Ythier H, Gilquin B, Duquesnoy B, Wemeau J . Influence of accompanying anion on intestinal radiocalcium absorption. Calcif Tissue Int. 1987; 40(1):8-11. DOI: 10.1007/BF02555721. View

Elders P, Netelenbos J, Lips P, van Ginkel F, Khoe E, Leeuwenkamp O . Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab. 1991; 73(3):533-40. DOI: 10.1210/jcem-73-3-533. View

Rico H, Revilla M, Hernandez E, Villa L, Alvarez del Buergo M . Total and regional bone mineral content in relation to menopause. Maturitas. 1992; 15(3):233-40. DOI: 10.1016/0378-5122(92)90207-k. View

Matkovic V . Calcium metabolism and calcium requirements during skeletal modeling and consolidation of bone mass. Am J Clin Nutr. 1991; 54(1 Suppl):245S-260S. DOI: 10.1093/ajcn/54.1.245S. View

Chan G . Dietary calcium and bone mineral status of children and adolescents. Am J Dis Child. 1991; 145(6):631-4. DOI: 10.1001/archpedi.1991.02160060049019. View

Baran D, Sorensen A, Grimes J, Lew R, Karellas A, Johnson B . Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: a three-year prospective study. J Clin Endocrinol Metab. 1990; 70(1):264-70. DOI: 10.1210/jcem-70-1-264. View

Cumming R . Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Int. 1990; 47(4):194-201. DOI: 10.1007/BF02555919. View

10.

Geusens P, Schot L, Nijs J, Dequeker J . Calcium-deficient diet in ovariectomized dogs limits the effects of 17 beta-estradiol and nandrolone decanoate on bone. J Bone Miner Res. 1991; 6(8):791-7. DOI: 10.1002/jbmr.5650060803. View

11.

Rico H, Cabranes J, Hernandez E, Perez del Molino J, Escudero G . Effect of calcium pidolate on biochemical and hormonal parameters in involutional osteoporosis. Maturitas. 1990; 12(2):105-11. DOI: 10.1016/0378-5122(90)90088-n. View

12.

Riis B, Thomsen K, Christiansen C . Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med. 1987; 316(4):173-7. DOI: 10.1056/NEJM198701223160401. View

13.

Rico H, Revilla M, Hernandez E, Villa L, Lopez-Alonso A . Total and regional bone mineral content in normal premenopausal women. Clin Rheumatol. 1991; 10(4):423-5. DOI: 10.1007/BF02206664. View

14.

Sartoris D, Resnick D . Current and innovative methods for noninvasive bone densitometry. Radiol Clin North Am. 1990; 28(2):257-78. View

15.

JOHNSTON Jr C, Miller J, Slemenda C, Reister T, Hui S, CHRISTIAN J . Calcium supplementation and increases in bone mineral density in children. N Engl J Med. 1992; 327(2):82-7. DOI: 10.1056/NEJM199207093270204. View

16.

Ekman M, Reizenstein P, Teigen S, Ronneberg R . Comparative absorption of calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet, and chloride solution. Bone. 1991; 12(2):93-7. DOI: 10.1016/8756-3282(91)90006-5. View

17.

Dawson-Hughes B, Dallal G, Krall E, Sadowski L, Sahyoun N, Tannenbaum S . A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med. 1990; 323(13):878-83. DOI: 10.1056/NEJM199009273231305. View

18.

Ettinger B, Genant H, Cann C . Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med. 1987; 106(1):40-5. DOI: 10.7326/0003-4819-106-1-40. View